Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Amantadine × Tumor-Agnostic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Surveys and Questionnaires 39 Blood Specimen Collection 18 Interviews as Topic 13 Data Collection 11 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Radiotherapy 5 Hematologic Tests 5 Restraint, Physical 4 Palliative Care 4 Mental Status and Dementia Tests 4 Registries 3 Quality of Life 3 Phlebotomy 3 Observation 3 Neoadjuvant Therapy 3 Lapatinib 3 Immunotherapy 3 Focus Groups 3 Drug Therapy 3 veliparib 2 talazoparib 2 rucaparib 2 pamiparib 2 olaparib 2 niraparib 2 Wearable Electronic Devices 2 Therapeutics 2 Radiosurgery 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02277938 2021-03-17

Acetylamantadine Excretion by Cancer Patients

University of Manitoba

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡